Does Rallies show Form 4 insider transactions for CARE?

Yes. Rallies tracks CARE insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CARE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CARE. It does not provide personalized investment advice.

CARE (Carter Bankshares, Inc. Common Stock) Stock Analysis - Insider Trades

Carter Bankshares, Inc. Common Stock (CARE) is a publicly traded Financial Services sector company. As of May 21, 2026, CARE trades at $26.78 with a market cap of $580.88M and a P/E ratio of 5.47. CARE moved +0.70% today. Year to date, CARE is +35.41%; over the trailing twelve months it is +66.92%. Its 52-week range spans $13.61 to $27.24. Analyst consensus is buy with an average price target of $27.00. Rallies surfaces CARE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CARE stock inside the company?

Recent CARE insider activity includes Langs Bradford N. sold 5.50K, Walsh Elizabeth L. bought 4.58K, Haskins James W. sold 1.00K, Bolton Robert M. sold 1.90K, and Speare Matthew M. sold 13.55K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CARE Key Metrics

Key financial metrics for CARE
Metric	Value
Price	$26.78
Market Cap	$580.88M
P/E Ratio	5.47
EPS	$4.87
Dividend Yield	0.10%
52-Week High	$27.24
52-Week Low	$13.61
Volume	230
Avg Volume	0
Revenue (TTM)	$23.49M
Net Income	$108.17M
Gross Margin	0.00%

Recent CARE Insider Trades

Langs Bradford N. sold 5.50K (~$145.56K) on May 12, 2026.
Walsh Elizabeth L. bought 4.58K (~$119.86K) on May 6, 2026.
Haskins James W. sold 1.00K (~$26.04K) on May 5, 2026.
Bolton Robert M. sold 1.90K (~$32.75K) on Oct 30, 2025.
Speare Matthew M. sold 13.55K (~$268.75K) on Sep 10, 2025.

Latest CARE News

Chief Strategy Officer Sells 5,500 Shares at $26.47 and Rolls Out No-Fee Youth Accounts — May 12, 2026
Carter Bankshares Posts $85.8M Q1 Profit, Reinstates $0.10 Dividend with 1.64% Yield — Apr 23, 2026

CARE Analyst Consensus

2 analysts cover CARE: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.00.

Common questions about CARE

Who is trading CARE stock inside the company?: Recent CARE insider activity includes Langs Bradford N. sold 5.50K, Walsh Elizabeth L. bought 4.58K, Haskins James W. sold 1.00K, Bolton Robert M. sold 1.90K, and Speare Matthew M. sold 13.55K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CARE?: Yes. Rallies tracks CARE insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CARE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CARE. It does not provide personalized investment advice.